Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A lazy portfolio uses a small number of broad investments to achieve broad diversification with minimal maintenance, making investing less time-consuming.
20,876 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A major institution disclosed a new roughly $5 million stake in Central Bancompany, helping fuel a 20% gain since its...
Explore how Uri Levine’s problem-first approach fuels startup success, from Waze’s ascent to the future of autonomous...
As the calendar closes on 2025, Ascendis (ASND) faces the final earnings closeout with questions about cash, pipeline...
The software sector has faced a sharp pullback, but not all names belong in the same bucket. This guide highlights ho...
Mortgage-report fees are climbing again as Experian and other bureaus raise pricing. Industry sources say the latest ...
BlackRock filed with the SEC on May 8 to launch two tokenized money market funds, including a digital class for BSTBL...
In 2026, a surge in COO-to-CEO moves signals a changing ladder to the corner office. Four distinct tracks define the ...
As job cuts persist in early 2026, employers cite AI adoption to explain restructuring. The trend underscores why wor...
A 200% jump in 2025 Russian airspace incursions into NATO territory marks a rapid escalation. Investors are reassessi...
Tech leadership returns as Nvidia and Meta strengthen AI bets. This rally lifted major indexes and helped smaller gro...
A fresh institutional stake has emerged in Victoria’s Secret stock this quarter. The $8.5 million bet suggests some m...